Transforming IP Portfolios into a Business Growth Engine
COZAREN empowers biopharma and agrochemical innovators to unlock the full potential of their IP. Using AI-driven chemical and biosequence searches, competitive intelligence and strategic advisory, we transform patents into strategic business assets to maximise value, mitigate risk and accelerate market success.
Maximise value. Reduce risk. Move faster.
Company Capabilities Overview
Patent & Competitive Intelligence Searches
Make decisions with confidence. Our patent and market intelligence services deliver critical insights for IP strategy, M&A, licensing and investment due diligence.
​
-
Novelty & patentability searches;
-
Validity & opposition searches;
-
Freedom-to-operate (FTO) analyses; and,
-
IP landscape & trend mapping to benchmark competitors and identify whitespace opportunities.
Due Diligence Support for IP Transactions
High-stakes deals demand precise, risk-informed insights. Partnering with experienced patent attorneys, we provide end-to-end IP due diligence across the lifecycle.
​
We support:
-
Licensing & acquisition evaluations.
-
Investment & partnership negotiations.
-
R&D collaborations & joint ventures.
-
Commercialisation readiness assessments
Patent Portfolio Optimisation & Licensing Opportunities
Your patents should drive growth, not sit idle. We align IP strategy with commercial objectives to maximise revenue, reduce risk, and unlock long-term value.
​
Our services include:
-
Licensing or litigation support to enforce patent rights.
-
Early infringement and litigation risk assessments to reduce exposure.
-
Acceleration of biopharma development and market entry with investor connections.
-
Identification of high-value licensing prospects, markets and R&D partners.
-
Monetisation of non-core or underused IP via licensing, transfer, divestiture or alternative financing.
-
Competitive intelligence to guide portfolio pruning and operational efficiency.
AI-Integrated Biosequence Search Platforms
Harness AI with gold-standard algorithms like BLAST and Smith-Waterman. Our scalable bioinformatics platforms empower IP, R&D and regulatory teams to work faster, smarter and with greater precision. For more, visit: www.genepat.com
Platform capabilities:
-
High-precision protein and nucleotide sequence searches.
-
Complementarity-determining region (CDR) searches.
-
Motif-based searches with up to five mismatches.
-
Hybrid searches combining sequence data and keyword filters.
About Cornelius Enuezie
Cornelius Enuezie, founder of COZAREN GmbH, brings over 28 years of experience in biopharmaceutical and agrochemical patents, combined with senior leadership roles across industry-leading organisations. His career includes key positions at global companies such as Novartis, IMS Health, Teva, and Clarivate, where he developed deep expertise at the intersection of science, intellectual property and commercial strategy.
Cornelius combines:
-
Advanced technical knowledge in chemical and biosequence patents
-
Strong commercial and strategic insight
-
Specialist expertise in patent search and competitive intelligence
This unique blend enables him to:
-
Build high-performing licensing and IP monetisation programmes
-
Identify untapped revenue opportunities within patent portfolios
-
Strengthen the revenue-generating capabilities of biopharmaceutical organisations
Proven ability to utilise technical knowledge, business acumen, specialist patent search and competitive intelligence research skills to facilitate an excellent record of building effective licensing and patent monetisation programmes and supplementing the revenue-generating activities of biopharmaceutical organisations.
Strategic Collaborations
​To deliver maximum value, COZAREN works in close collaboration with trusted partners, including:
​
-
Westberg IP GmbH (s@westbergip.ch)
-
As a member of Novacon IP (www.novacon-ip.com)
-
Biosequence platform development (https://azati.ai)
These partnerships enhance COZAREN’s ability to deliver integrated, high-impact IP solutions across global markets.
